Nelson's Syndrome: An Update.
Bilateral adrenalectomy
Corticotroph tumor progression
Cushing’s
Nelson’s syndrome
Tumor growth
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
Nelson's syndrome (NS) is a condition which may develop in patients with Cushing's disease after bilateral adrenalectomy. Although there is no formal consensus on what defines NS, corticotroph tumor growth and/or gradually increasing ACTH levels are important diagnostic elements. Pathogenesis is unclear and well-established predictive factors are lacking; high ACTH during the first year after bilateral adrenalectomy is the most consistently reported predictive parameter. Management is individualized and includes surgery, with or without radiotherapy, radiotherapy alone, and observation; medical treatments have shown inconsistent results. A subset of tumors demonstrates aggressive behavior with challenging management, malignant transformation and poor prognosis.
Identifiants
pubmed: 32741480
pii: S0889-8529(20)30031-1
doi: 10.1016/j.ecl.2020.05.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
413-432Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose. This work did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.